Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
"Nice report....however they are talking fall of ‘19 for the real action to start..."
I disagree. The Zacks report indicates that Resverlogix plans to submit its Phase III data to the FDA and other regulatory authorities in fall '19. There is always a lag between trial results and FDA/EMA submissions. No surprise there. If H1 2019 top-line results are positive, it will be a wild ride well before fall '19!
